Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance
Cancer Drug Resistance · 20.01.2026
DOI: 10.20517/cdr.2025.189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Drug Resistance, online erschienen am 20.01.2026. Verfasst von Yang Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The reciprocal feedback between cancer stem cells (CSCs) and cancer-associated fibroblasts (CAFs) is increasingly recognized as a driver of therapeutic resistance and tumor evolution. According to the “soil and seed” hypothesis, CAFs create a biochemical and biomechanical “soil” for CSCs to seed, grow, and thrive. In turn, CSCs manipulate and transform fibroblasts to promote CSC traits, thus completing the loop of CAF-CSC crosstalk through bidirectional molecular communication within the tumor microenvironment. This review encompasses recent advances in CAF heterogeneity, including conserved and malignancy-specific subtypes, as well as the molecular dialogue driving resistance. We also briefly discuss emerging therapeutic approaches, particularly the potential of natural compounds to target both CSCs and CAFs. By bridging mechanistic insights with translational innovations, this review provides a roadmap for breaking the CSC-CAF alliance, offering hope for overcoming therapeutic resistance and improving cancer outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.
- Yu-Yue Pathology Scientific Research Center, Chongqing 400039, China.
- Jinfeng Laboratory, Chongqing 401329, China.
- Department of Oncology & Cancer Institute, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610042, Sichuan, China.
- These authors contributed equally to this work.
- Pathology Department, Shiyan Taihe Hospital, Shiyan 442000, Hubei, China.
Zitieren
APA
Shen, Y., Sun, Y., Li, X., Wang, Y., Huang, T., Li, T., Zhu, Y. Z., Hu, L., & Xu, C. (2026). Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance. Cancer Drug Resistance. https://doi.org/10.20517/cdr.2025.189
Vancouver
Shen Y, Sun Y, Li X, Wang Y, Huang T, Li T, et al. Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance. Cancer Drug Resistance. 2026. doi:10.20517/cdr.2025.189
BibTeX
@article{Shen2026,
author = {Shen, Yang and Sun, Yuting and Li, Xurui and Wang, Yi and Huang, Ting and Li, Ting and Zhu, Yi-Zhun and Hu, Lanlin and Xu, Chuan},
title = {Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance},
journal = {Cancer Drug Resistance},
year = {2026},
doi = {10.20517/cdr.2025.189}
}
EUVIMED